Skip to main content

Advertisement

Figure 2 | BMC Research Notes

Figure 2

From: Effect of pegloticase on renal function in patients with chronic kidney disease: a post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trials

Figure 2

Percentage of patients with a change in eGFR by categories of change. Change was calculated as the percentage change from baseline in the minimum eGFR observed at post-randomization visit. Categories of change were derived as a proxy for severity of renal function decline. Percentages are presented by randomized treatment group. PGL = pegloticase.

Back to article page